Advance your Career in Dermatopathology

The Dermatopathology Career Development Award (CDA) supports the academic career development of future intellectual leaders who demonstrate a strong commitment to advance the fields of dermatopathology and dermatology through research and/or education. 

trnava-university-Lr_MKzNGhUU-unsplash

Know Before You Apply

All Foundation-funded research must be conducted in the U.S. under the sponsorship of a department/division of dermatology that is ACGME-approved for training in dermatology. Applicants must meet the DF’s general eligibility requirements, in addition to award-specific requirements presented on or before the time of funding. Minority applicants are encouraged to apply.

The DF encourages applications concerning health issues impacting minority groups, including, but not limited to, racial minorities, sexual¬ gender/LGBTQ minorities, and underserved/disadvantaged populations.

Am I eligible?

If you meet all of the requirements below, you may be eligible to apply for the Dermatopathology Research Career Development Award.

  • M.D.; M.D., Ph.D.; or D.O. degree
  • Completed training in a U.S. dermatology or pathology residency program and a U.S. fellowship program in dermatopathology
  • Under the mentorship of an experienced investigator(s)
  • Mentor must have an academic appointment in dermatology or another program at the sponsoring institution that is approved by the dermatology chair
  • Demonstrates a strong commitment to skin research that can advance the field of dermatopathology

How do I apply for the Dermatopathology Research Career Development Award?

The PDF application instructions provide essential information potential applicants need to know to evaluate the various award opportunities and develop a successful application and research proposal. Interested individuals are strongly encouraged to read sections II and III before beginning any paperwork.

Application deadline: October 15, 2021

Featured Researcher

Biomarker Analysis of Transcriptome Signatures in Mycosis Fungoides Across Clinicopathologic Stages

Mycosis Fungoides (MF) is a rare disease that is difficult to diagnose and treat. Recent studies on the genomic signature of this disease have shown that MF is difficult to fully characterize. We propose that dissecting lymphocytes from affected tissue and performing transcriptome-based studies and biomarker analysis will allow us to improve diagnosis and treatment of MF across the clinical stages of this disease.

D-CDA-Paul-Haun-Lite

Paul Haun, M.D.

University of Pennsylvania

Dermatopathology Research Career Development Award

Award Recipients | Dermatopathology Research Career Development Award

Paul L. Haun, M.D. 
University of Pennsylvania 
Biomarker Analysis of Transcriptome Signatures in Mycosis Fungoides Across Clinicopathologic Stages 

Joel C. Sunshine, M.D., Ph.D. 
Johns Hopkins University 
Loss of Effective Antigen Presentation in Melanoma and Treatment Failure 

Randie Hee Kim, M.D., Ph.D. – Year 3 
New York University 
Using Artificial Intelligence to Improve Prognosis of Intermediate Thickness Melanomas 

Ursula E. Lang, M.D., Ph.D. – Year 3 
University of California, San Francisco 
Investigating the Role of Primary Cilia in Melanocytes and Melanomagenesis